DE69012796D1 - Jodierte ester. - Google Patents

Jodierte ester.

Info

Publication number
DE69012796D1
DE69012796D1 DE69012796T DE69012796T DE69012796D1 DE 69012796 D1 DE69012796 D1 DE 69012796D1 DE 69012796 T DE69012796 T DE 69012796T DE 69012796 T DE69012796 T DE 69012796T DE 69012796 D1 DE69012796 D1 DE 69012796D1
Authority
DE
Germany
Prior art keywords
pct
group
unsubstituted
substituted
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69012796T
Other languages
English (en)
Other versions
DE69012796T2 (de
Inventor
Jo Klaveness
Per Strande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Publication of DE69012796D1 publication Critical patent/DE69012796D1/de
Application granted granted Critical
Publication of DE69012796T2 publication Critical patent/DE69012796T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0476—Particles, beads, capsules, spheres
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/88—Carboxylic acid amides having nitrogen atoms of carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C07D317/36—Alkylene carbonates; Substituted alkylene carbonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
DE69012796T 1989-01-09 1990-01-08 Jodierte ester. Expired - Fee Related DE69012796T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898900376A GB8900376D0 (en) 1989-01-09 1989-01-09 Iodinated esters
PCT/EP1990/000053 WO1990007491A1 (en) 1989-01-09 1990-01-08 Iodinated esters

Publications (2)

Publication Number Publication Date
DE69012796D1 true DE69012796D1 (de) 1994-10-27
DE69012796T2 DE69012796T2 (de) 1995-02-02

Family

ID=10649773

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69012796T Expired - Fee Related DE69012796T2 (de) 1989-01-09 1990-01-08 Jodierte ester.

Country Status (18)

Country Link
US (3) US5370861A (de)
EP (1) EP0452377B1 (de)
JP (1) JP2703111B2 (de)
AT (1) ATE111889T1 (de)
AU (1) AU631837B2 (de)
CA (1) CA2045543C (de)
DE (1) DE69012796T2 (de)
DK (1) DK0452377T3 (de)
ES (1) ES2060138T3 (de)
FI (1) FI912664A0 (de)
GB (1) GB8900376D0 (de)
HU (1) HU214328B (de)
IE (1) IE64500B1 (de)
NO (1) NO300968B1 (de)
NZ (1) NZ232050A (de)
RU (1) RU2088579C1 (de)
WO (1) WO1990007491A1 (de)
ZA (1) ZA90143B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
AU642066B2 (en) * 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
SE470086B (sv) * 1991-04-23 1993-11-08 Kabi Pharmacia Ab Organspecifik emulsion
CA2112109A1 (en) * 1991-07-05 1993-01-21 Arne Berg Improvements in or relating to contrast agents
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
DE69230885T3 (de) * 1991-09-17 2008-01-24 Ge Healthcare As Gasförmige ultraschallkontrastmittel
US5674468A (en) * 1992-03-06 1997-10-07 Nycomed Imaging As Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
US5330739A (en) * 1992-12-04 1994-07-19 Sterling Winthrop Inc. Iodinated benzoyl acetals and ketals for x-ray imaging
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
CZ191695A3 (en) * 1993-01-25 1996-05-15 Sonus Pharma Inc Biologically compatible contrast agent, process of its preparation and representation method by ultrasound
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
NO940115D0 (no) * 1994-01-13 1994-01-13 Nycomed Imaging As Kontrastmidler for roentgen- og magnettomografisk avbildning
US5686061A (en) * 1994-04-11 1997-11-11 The Board Of Regents Of The University Of Texas System Particulate contrast media derived from non-ionic water soluble contrast agents for CT enhancement of hepatic tumors
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
IT1271134B (it) * 1994-12-01 1997-05-26 Bracco Spa Derivati iodurati del bifenile e loro impiego diagnostico
US5543133A (en) * 1995-02-14 1996-08-06 Nanosystems L.L.C. Process of preparing x-ray contrast compositions containing nanoparticles
DE19622283A1 (de) * 1996-05-23 1997-11-27 Schering Ag Verfahren zur terminalen Sterilisierung von befüllten Spritzen
US6017310A (en) * 1996-09-07 2000-01-25 Andaris Limited Use of hollow microcapsules
US5925683A (en) * 1996-10-17 1999-07-20 Target Therapeutics, Inc. Liquid embolic agents
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
FR2784580B1 (fr) * 1998-10-16 2004-06-25 Biosepra Inc Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
DE60139112D1 (de) * 2000-03-06 2009-08-13 Boston Scient Ltd Unter ultralschall sichtbare embolisierende substanzen
WO2002060975A1 (en) 2001-01-31 2002-08-08 The Procter & Gamble Company Synthesis of polyol medium fatty acid polyesters
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
WO2003105917A2 (en) 2002-06-12 2003-12-24 Scimed Life Systems, Inc. Bulking agents
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US20140065067A1 (en) 2010-12-17 2014-03-06 Universite De Strasbourg Radiopaque iodinated products intended for use medical imaging and their methods
WO2013121284A1 (en) 2012-02-14 2013-08-22 Universite De Strasbourg Iodinated products intended for a use for the medical imaging and their methods of preparation
JP6124273B2 (ja) * 2012-02-29 2017-05-10 国立大学法人金沢大学 分子イメージングにより代謝機能を測定するための検査薬

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL239757A (de) * 1958-06-03
GB1363847A (en) * 1970-09-09 1974-08-21 Beecham Group Ltd Iodinated organic acid derivatives for use as x-ray contrast agents
US4018783A (en) * 1970-09-09 1977-04-19 Beecham Group Limited Esters of metrizoic acid
LU80207A1 (de) * 1978-09-07 1980-04-21 H Kalbacher Neue substituierte kohlensaeureester und urethane,verfahren zu ihrer herstellung und deren verwendung
GB2157283B (en) * 1984-03-30 1987-07-08 Squibb & Sons Inc Esters of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters

Also Published As

Publication number Publication date
RU2088579C1 (ru) 1997-08-27
NO912671D0 (no) 1991-07-08
CA2045543C (en) 2000-03-14
JP2703111B2 (ja) 1998-01-26
HUT57700A (en) 1991-12-30
AU4814290A (en) 1990-08-01
HU214328B (hu) 1998-03-02
CA2045543A1 (en) 1990-07-10
IE900065L (en) 1990-07-09
EP0452377B1 (de) 1994-09-21
ATE111889T1 (de) 1994-10-15
ZA90143B (en) 1990-10-31
FI912664A0 (fi) 1991-06-03
DK0452377T3 (da) 1994-10-17
US5416223A (en) 1995-05-16
DE69012796T2 (de) 1995-02-02
WO1990007491A1 (en) 1990-07-12
ES2060138T3 (es) 1994-11-16
JPH04502617A (ja) 1992-05-14
NO912671L (no) 1991-07-08
NZ232050A (en) 1991-07-26
GB8900376D0 (en) 1989-03-08
NO300968B1 (no) 1997-08-25
US5370861A (en) 1994-12-06
IE64500B1 (en) 1995-08-09
EP0452377A1 (de) 1991-10-23
AU631837B2 (en) 1992-12-10
US5559266A (en) 1996-09-24

Similar Documents

Publication Publication Date Title
DE69012796D1 (de) Jodierte ester.
ES8106696A1 (es) Procedimiento para la preparacion de bis-(hidroxialcohilami-das)de acidos 5-(n-alcohil-a-hidroxiacil-amino)-2,4,6-triyo-do-isoftalicos
ATE201019T1 (de) 9-deoxotaxan verbindungen
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
NZ194850A (en) Substituted oxirane-carboxylic acids pharmaceutical compositions
EP0398720A3 (de) Piperazin-Derivate
KR920000335A (ko) 영상제로서 거대환상 아미노포스폰산 착체의 용도
RU93005114A (ru) Пенемовые соединения и фармацевтическая композиция на их основе
DK638088D0 (da) Substituerede dicarboxylsyre-bis(3,5-dicarbamoyl-2,4,6-trijodanilider), fremgangsmaade til fremstilling deraf samt roentgenkontrastmidler indeholdende disse
FI905883A (fi) Röntgenvarjoaineina käyttökelpoisia 5-amino-2,4,6-trijodi-1,3-bentseenidikarboksiamidojohdannaisia ja menetelmä niiden valmistamiseksi
ATE73763T1 (de) Jodierte ester.
KR880700813A (ko) 노르-콜란산 유도체,그의 제조방법, 그의 용도 및 이를 함유하는 약제학적 조성물
IL67285A (en) 7-(2-(2-amino-4-thiazolyl)-2-oxyiminoacetamido)-3-cephem-3-heterocyclyl-thiomethyl-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ATE1066T1 (de) Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahy dro-1h-1-benzazepin-2-ons, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
CA2021173A1 (en) Radioactive diagnostic agent
ES2021944A6 (es) Procedimiento para preparar nuevos derivados de 1,3,5,-triamino-2,4,6-triyodobenceno.
FR2412309A1 (fr) Compositions a base de derives d'isothiouree et leurs applications
PL292899A1 (en) Fodder compositions for use in farming animals as well as compositions in the form of fodder additives, premixtures and ready-to-use fodder containing novel isoquinoline derivatives and method of obtaining such compositions
TH10969EX (th) อนุพันธ์เบนซิไซไธโออะโวลิโนน-1-ไดออกไซด์ในรูปสารยับยั้งเอนไซม์อีลาสเทส
HUP9801407A1 (hu) Antiplazmid hatású benzolsavszármazékok és ezeket tartalmazó gyógyszerkészítmények, továbbá eljárás előállításukra

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee